Effects of apolipoprotein A-I genetic variations on plasma apolipoprotein, serum lipoprotein and glucose levels (Q43986435)

28 November 2017

title

Effects of apolipoprotein A-I genetic variations on plasma apolipoprotein, serum lipoprotein and glucose levels (English)

1 reference

28 November 2017

0 references

0 references

1 reference

2

1 reference

28 November 2017

Larson IA

1

1 reference

28 November 2017

Barnard JR

3

1 reference

28 November 2017

Hoffmann MM

4

1 reference

28 November 2017

Feussner G

5

1 reference

28 November 2017

Lamon-Fava S

6

1 reference

28 November 2017

Schaefer EJ

7

1 reference

28 November 2017

publication date

1 March 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

61

1 reference

28 November 2017

issue

3

1 reference

28 November 2017

page(s)

176-184

1 reference

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

Familial deficiency of apolipoproteins A-I and C-III and precocious coronary-artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

A protein cofactor of lecithin:cholesterol acyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

Isolation and characterization of the human apolipoprotein A-I gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII, and AIV genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

Nucleotide sequence of cloned cDNA of human apolipoprotein A-l

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

Localization of the structural gene for human apolipoprotein A-I on the long arm of human chromosome 11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

DNA polymorphisms of the apolipoprotein genes--their use in the investigation of the genetic component of hyperlipidaemia and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

Deoxyribonucleic acid polymorphism in the apolipoprotein A-1-C-III gene cluster. Association with hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

Apolipoprotein A-I gene polymorphisms: frequency in patients with coronary artery disease and healthy controls and association with serum apo A-I and HDL-cholesterol concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus Relationships with lipids, apolipoproteins, and premature coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

G-->A substitution at position -75 of the apolipoprotein A-I gene promoter. Evidence against a direct effect on HDL cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

Influence of apolipoprotein A-1 promoter polymorphism on lipid levels and responses to dietary change in Finnish adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

Polymorphism in the promoter region of the apolipoprotein AI gene associated with differences in apolipoprotein AI levels: the European Atherosclerosis Research Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

New MspI polymorphism at 83 bp of the human apolipoprotein AI gene: association with increased circulating high density lipoprotein cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

Influence of mutation in human apolipoprotein A-1 gene promoter on plasma LDL cholesterol response to dietary fat

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

Evaluation of G-to-A substitution in the apolipoprotein A-I gene promoter as a determinant of high-density lipoprotein cholesterol level in subjects with and without cholesteryl ester transfer protein deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

Polymorphisms at the 5'-end of the apolipoprotein AI gene and severity of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

Influence of genetic variation at the apo A-I gene locus on lipid levels and response to diet in familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

Human apolipoprotein A-I gene promoter mutation influences plasma low density lipoprotein cholesterol response to dietary fat saturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

Association of apolipoprotein (Apo)E genotype with plasma apo E levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

Estrogen increases apolipoprotein (apo) A-I secretion in hep G2 cells by modulating transcription of the apo A-I gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

The A/G polymorphism in the -78 position of the apolipoprotein A-I promoter does not have a direct effect on transcriptional efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

7 January 2021

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

7 January 2021

Epidemiological correlates of high density lipoprotein subfractions, apolipoproteins A-I, A-II, and D, and lecithin cholesterol acyltransferase. Effects of smoking, alcohol, and adiposity

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

7 January 2021

Apolipoprotein profile in healthy males and its relation to maximum aerobic capacity (MAC)

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

7 January 2021

Effect of alcohol intake and exercise on plasma high-density lipoprotein cholesterol subfractions and apolipoprotein A-I in women

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

7 January 2021

Inheritance of high density lipoprotein and lipoprotein lipase and hepatic lipase activity

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

7 January 2021

C to T and/or G to A transitions are responsible for loss of a MspI restriction site at the 5'-end of the human apolipoprotein AI gene

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

7 January 2021

Interaction between a polymorphism of the apo A-I promoter region and smoking determines plasma levels of HDL and apo A-I

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

7 January 2021

Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

7 January 2021

Role of genetic variation at the apo AI-CIII-AIV gene cluster in determining plasma apo AI levels in boys and girls

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

7 January 2021

Five restriction fragment length polymorphisms of the APOA1-C3 gene and their influence on lipids and apolipoproteins in healthy Chinese

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

7 January 2021

Haplotype analysis of two APOA1/MspI polymorphisms in relation to plasma levels of apo A-I and HDL-cholesterol

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

7 January 2021

Adenine for guanine substitution -78 base pairs 5' to the apolipoprotein (APO) A-I gene: relation with high density lipoprotein cholesterol and APO A-I concentrations

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

7 January 2021

Mild association between the A/G polymorphism in the promoter of the apolipoprotein A-I gene and apolipoprotein A-I levels: A meta-analysis

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

7 January 2021

Apolipoprotein A1 gene polymorphisms and risk of early coronary disease

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

7 January 2021

MspI polymorphism at 83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

7 January 2021

Genetic markers in the apo AI-CIII-AIV gene cluster for combined hyperlipidemia, hypertriglyceridemia, and predisposition to atherosclerosis

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

7 January 2021

A study of DNA polymorphisms around the human apolipoprotein AI gene in hyperlipidaemic and normal individuals

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

7 January 2021

Restriction fragment length polymorphisms at the apoprotein genes AI, CIII and B‐100 and in the 5‘ flanking region of the insulin gene as possible markers of coronary heart disease

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

7 January 2021

Influence of the SstI polymorphism at the apolipoprotein C-III gene locus on the plasma low-density-lipoprotein-cholesterol response to dietary monounsaturated fat

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2002.610302.X

7 January 2021

10.1034/J.1399-0004.2002.610302.X

Identifiers

DOI

1 reference

28 November 2017

1 reference